Dave Perrill - 07 May 2026 Form 4 Insider Report for HIVE Digital Technologies Ltd. (HIVE)

Reporting relationship: Director
Issuer ticker: HIVE
Reported as of: 07 May 2026
Net transaction value: -$820,750
SEC form: 4
Accepted by SEC: 23 Jun 2026, 18:49:14 UTC
Prior SEC filing: 31 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Dave Perrill

Key filing fact

Dave Perrill filed Form 4 for HIVE Digital Technologies Ltd. (HIVE) on 23 Jun 2026.

Key facts

This page summarizes Dave Perrill's Form 4 filing for HIVE Digital Technologies Ltd. (HIVE).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 Jun 2026, 18:49.

Change

Previous filing in this sequence was filed on 31 Mar 2026.
Current net transaction value: -$820,750.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002123299 Primary reporting owner

Perrill Dave

Relationship: Director
Address: 7900 CALLAGHAN ROAD, SUITE 128, SAN ANTONIO
Signature: /s/ Dave Perrill
Signature date: 23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIVE transaction

Common Shares

Options Exercise

Transaction value
Shares: +100,000
Change %: +160%
Price
Shares after: 162,500
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

HIVE transaction

Common Shares

Options Exercise

Transaction value
Shares: +12,500
Change %: +7.7%
Price
Shares after: 175,000
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

HIVE transaction

Common Shares

Sale

Transaction value: $820,750
Shares: -175,000
Change %: -100%
Price: $4.69
Shares after: 0
Date: 19 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIVE transaction Derivative

Restricted stock units

Options Exercise

Transaction value
Shares: -100,000
Change %: -23%
Price: $0.000000^*
Shares after: 337,500
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price
Footnotes: F1, F3

HIVE transaction Derivative

Restricted stock units

Options Exercise

Transaction value
Shares: -12,500
Change %: -3.7%
Price: $0.000000^*
Shares after: 325,000
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price
Footnotes: F1, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects restricted share units ("RSUs") issued pursuant to the Issuer's Restricted Share Unit Plan (the "RSU Plan") that, upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from C$6.589 to C$6.660, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The weighted average price reported above was converted from the Canadian weighted average price of C$6.639 to USD$4.57, using an exchange rate of USD$1.00 = C$0.705, as reported by the Bank of Canada on June 19, 2026.

Footnote F3

Reflects 100,000 RSUs that were awarded on April 17, 2025 and vested on April 17, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan.

Footnote F4

Reflects 12,500 RSUs that were awarded on November 5, 2024 and vested on May 5, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan.

Footnote F5

Reflects additional RSU awards that have not vested and converted that were previously reported. The underlying shares and vesting schedules are as follows: (i) 25,000 vest in two equal installments of 12,500 on each of August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.